Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Nejman-Gryz (Warszawa, Poland), K. Górska (Warszawa, Poland), M. Paplinska-Goryca (Warszawa, Poland), M. Proboszcz (Warszawa, Poland), R. Krenke (Warszawa, Poland). Periostin and TSLP-a potential crosstalk in obstructive airway diseases. 621

Member's Comments

No comment yet.

Related content which might interest you: Periostin as a marker of Th2-related inflammation in patients with different types of chronic obstructive airway disease Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 The lung microbiome in obstructive airways disease: potential pathogenetic roles Source: Eur Respir Monogr 2019; 83: 140-157 Year: 2019 The role of small airways in obstructive airway diseases Source: Eur Respir Rev 2011; 20: 23-33 Year: 2011 The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Bacterial load in chronic obstructive pulmonary disease and its relationship with airway inflammation and lung function Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Inflammatory cell microlocalisation and airway dysfunction: cause and effect? Source: Eur Respir J 2007; 30: 1043-1056 Year: 2007 The role of cluster analysis in defining phenotypes of obstructive airway diseases: is there a need for a new taxonomy of obstructive airway diseases? Source: Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD Year: 2011 Airway epithelial inflammatory responses and clinical parameters in COPD Source: Eur Respir J 2003; 22: 94-99 Year: 2003 Epigenetic-like regulation of signalling proteins in chronic obstructive pulmonary disease Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms Year: 2019 Multiple inflammatory hits and the pathogenesis of severe airway disease Source: Eur Respir J 2006; 27: 884-888 Year: 2006 Mucus production in chronic obstructive lung diseases: relationship with infections Source: Annual Congress 2006 - Infections and chronic obstructive lung diseases Year: 2006 Clinical relevance of airway remodelling in airway diseases Source: Eur Respir J 2007; 30: 134-155 Year: 2007 Mucine secretion by airways epithelial cells in chronic obstructive lung disease Source: Annual Congress 2004 - Epithelial - microenvironmental interactions in neoplastic and non-neoplastic lung diseases Year: 2004 The role of inflamatory markers in obstructive pulmonary disease Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care Year: 2012 The relationship between fibroblasts and airway structure in patients with asthma and chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 148s Year: 2001 Small airway inflammation in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 501s Year: 2001 The link between inflammation and lung cancer: lessons from chronic obstructive pulmonary disease Source: International Congress 2018 – Scientific Year in Review Year: 2018 Pattern of airway inflammation and remodeling in mild chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Association between airway inflammation and systemic inflammation in stable chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Periostin levels in chronic obstructive pulmonary disease (COPD) Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018